Global Blood Plasma Derivatives Market Research Report 2023

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.

The global Blood Plasma Derivatives market was valued at US$ 33720 million in 2022 and is anticipated to reach US$ 47030 million by 2029, witnessing a CAGR of 5.7% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.

This report aims to provide a comprehensive presentation of the global market for Blood Plasma Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Derivatives.

The Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Plasma Derivatives market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood Plasma Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Albumin

1.2.3 Factor VIII

1.2.4 Factor IX

1.2.5 Immunoglobulin

1.2.6 Hyperimmune Globulin

1.2.7 Others

1.3 Market by Application

1.3.1 Global Blood Plasma Derivatives Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other End Users

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Blood Plasma Derivatives Market Perspective (2018-2029)

2.2 Blood Plasma Derivatives Growth Trends by Region

2.2.1 Global Blood Plasma Derivatives Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Blood Plasma Derivatives Historic Market Size by Region (2018-2023)

2.2.3 Blood Plasma Derivatives Forecasted Market Size by Region (2024-2029)

2.3 Blood Plasma Derivatives Market Dynamics

2.3.1 Blood Plasma Derivatives Industry Trends

2.3.2 Blood Plasma Derivatives Market Drivers

2.3.3 Blood Plasma Derivatives Market Challenges

2.3.4 Blood Plasma Derivatives Market Restraints

3.1 Global Top Blood Plasma Derivatives Players by Revenue

3.1.1 Global Top Blood Plasma Derivatives Players by Revenue (2018-2023)

3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2018-2023)

3.2 Global Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Blood Plasma Derivatives Revenue

3.4 Global Blood Plasma Derivatives Market Concentration Ratio

3.4.1 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Derivatives Revenue in 2022

3.5 Blood Plasma Derivatives Key Players Head office and Area Served

3.6 Key Players Blood Plasma Derivatives Product Solution and Service

3.7 Date of Enter into Blood Plasma Derivatives Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Blood Plasma Derivatives Historic Market Size by Type (2018-2023)

4.2 Global Blood Plasma Derivatives Forecasted Market Size by Type (2024-2029)

5.1 Global Blood Plasma Derivatives Historic Market Size by Application (2018-2023)

5.2 Global Blood Plasma Derivatives Forecasted Market Size by Application (2024-2029)

6.1 North America Blood Plasma Derivatives Market Size (2018-2029)

6.2 North America Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Blood Plasma Derivatives Market Size by Country (2018-2023)

6.4 North America Blood Plasma Derivatives Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Blood Plasma Derivatives Market Size (2018-2029)

7.2 Europe Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Blood Plasma Derivatives Market Size by Country (2018-2023)

7.4 Europe Blood Plasma Derivatives Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Blood Plasma Derivatives Market Size (2018-2029)

8.2 Asia-Pacific Blood Plasma Derivatives Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2018-2023)

8.4 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Blood Plasma Derivatives Market Size (2018-2029)

9.2 Latin America Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Blood Plasma Derivatives Market Size by Country (2018-2023)

9.4 Latin America Blood Plasma Derivatives Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Blood Plasma Derivatives Market Size (2018-2029)

10.2 Middle East & Africa Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2018-2023)

10.4 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Grifols

11.1.1 Grifols Company Detail

11.1.2 Grifols Business Overview

11.1.3 Grifols Blood Plasma Derivatives Introduction

11.1.4 Grifols Revenue in Blood Plasma Derivatives Business (2018-2023)

11.1.5 Grifols Recent Development

11.2 SK Plasma

11.2.1 SK Plasma Company Detail

11.2.2 SK Plasma Business Overview

11.2.3 SK Plasma Blood Plasma Derivatives Introduction

11.2.4 SK Plasma Revenue in Blood Plasma Derivatives Business (2018-2023)

11.2.5 SK Plasma Recent Development

11.3 Fusion Health Care

11.3.1 Fusion Health Care Company Detail

11.3.2 Fusion Health Care Business Overview

11.3.3 Fusion Health Care Blood Plasma Derivatives Introduction

11.3.4 Fusion Health Care Revenue in Blood Plasma Derivatives Business (2018-2023)

11.3.5 Fusion Health Care Recent Development

11.4 Biotest AG

11.4.1 Biotest AG Company Detail

11.4.2 Biotest AG Business Overview

11.4.3 Biotest AG Blood Plasma Derivatives Introduction

11.4.4 Biotest AG Revenue in Blood Plasma Derivatives Business (2018-2023)

11.4.5 Biotest AG Recent Development

11.5 Green Cross Corporation

11.5.1 Green Cross Corporation Company Detail

11.5.2 Green Cross Corporation Business Overview

11.5.3 Green Cross Corporation Blood Plasma Derivatives Introduction

11.5.4 Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2018-2023)

11.5.5 Green Cross Corporation Recent Development

11.6 Baxter International

11.6.1 Baxter International Company Detail

11.6.2 Baxter International Business Overview

11.6.3 Baxter International Blood Plasma Derivatives Introduction

11.6.4 Baxter International Revenue in Blood Plasma Derivatives Business (2018-2023)

11.6.5 Baxter International Recent Development

11.7 LFB

11.7.1 LFB Company Detail

11.7.2 LFB Business Overview

11.7.3 LFB Blood Plasma Derivatives Introduction

11.7.4 LFB Revenue in Blood Plasma Derivatives Business (2018-2023)

11.7.5 LFB Recent Development

11.8 Octapharma AG

11.8.1 Octapharma AG Company Detail

11.8.2 Octapharma AG Business Overview

11.8.3 Octapharma AG Blood Plasma Derivatives Introduction

11.8.4 Octapharma AG Revenue in Blood Plasma Derivatives Business (2018-2023)

11.8.5 Octapharma AG Recent Development

11.9 CSL Limited

11.9.1 CSL Limited Company Detail

11.9.2 CSL Limited Business Overview

11.9.3 CSL Limited Blood Plasma Derivatives Introduction

11.9.4 CSL Limited Revenue in Blood Plasma Derivatives Business (2018-2023)

11.9.5 CSL Limited Recent Development

11.10 Takeda

11.10.1 Takeda Company Detail

11.10.2 Takeda Business Overview

11.10.3 Takeda Blood Plasma Derivatives Introduction

11.10.4 Takeda Revenue in Blood Plasma Derivatives Business (2018-2023)

11.10.5 Takeda Recent Development

11.11 China Biologic Products

11.11.1 China Biologic Products Company Detail

11.11.2 China Biologic Products Business Overview

11.11.3 China Biologic Products Blood Plasma Derivatives Introduction

11.11.4 China Biologic Products Revenue in Blood Plasma Derivatives Business (2018-2023)

11.11.5 China Biologic Products Recent Development

11.12 Kedrion Biopharma

11.12.1 Kedrion Biopharma Company Detail

11.12.2 Kedrion Biopharma Business Overview

11.12.3 Kedrion Biopharma Blood Plasma Derivatives Introduction

11.12.4 Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2018-2023)

11.12.5 Kedrion Biopharma Recent Development

11.13 BDI Pharma

11.13.1 BDI Pharma Company Detail

11.13.2 BDI Pharma Business Overview

11.13.3 BDI Pharma Blood Plasma Derivatives Introduction

11.13.4 BDI Pharma Revenue in Blood Plasma Derivatives Business (2018-2023)

11.13.5 BDI Pharma Recent Development

11.14 Bayer AG

11.14.1 Bayer AG Company Detail

11.14.2 Bayer AG Business Overview

11.14.3 Bayer AG Blood Plasma Derivatives Introduction

11.14.4 Bayer AG Revenue in Blood Plasma Derivatives Business (2018-2023)

11.14.5 Bayer AG Recent Development

11.15 Hualan Biological Engineering

11.15.1 Hualan Biological Engineering Company Detail

11.15.2 Hualan Biological Engineering Business Overview

11.15.3 Hualan Biological Engineering Blood Plasma Derivatives Introduction

11.15.4 Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2018-2023)

11.15.5 Hualan Biological Engineering Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Blood Plasma Derivatives Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Albumin

    Table 3. Key Players of Factor VIII

    Table 4. Key Players of Factor IX

    Table 5. Key Players of Immunoglobulin

    Table 6. Key Players of Hyperimmune Globulin

    Table 7. Key Players of Others

    Table 8. Global Blood Plasma Derivatives Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Blood Plasma Derivatives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Blood Plasma Derivatives Market Size by Region (2018-2023) & (US$ Million)

    Table 11. Global Blood Plasma Derivatives Market Share by Region (2018-2023)

    Table 12. Global Blood Plasma Derivatives Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 13. Global Blood Plasma Derivatives Market Share by Region (2024-2029)

    Table 14. Blood Plasma Derivatives Market Trends

    Table 15. Blood Plasma Derivatives Market Drivers

    Table 16. Blood Plasma Derivatives Market Challenges

    Table 17. Blood Plasma Derivatives Market Restraints

    Table 18. Global Blood Plasma Derivatives Revenue by Players (2018-2023) & (US$ Million)

    Table 19. Global Blood Plasma Derivatives Market Share by Players (2018-2023)

    Table 20. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2022)

    Table 21. Ranking of Global Top Blood Plasma Derivatives Companies by Revenue (US$ Million) in 2022

    Table 22. Global 5 Largest Players Market Share by Blood Plasma Derivatives Revenue (CR5 and HHI) & (2018-2023)

    Table 23. Key Players Headquarters and Area Served

    Table 24. Key Players Blood Plasma Derivatives Product Solution and Service

    Table 25. Date of Enter into Blood Plasma Derivatives Market

    Table 26. Mergers & Acquisitions, Expansion Plans

    Table 27. Global Blood Plasma Derivatives Market Size by Type (2018-2023) & (US$ Million)

    Table 28. Global Blood Plasma Derivatives Revenue Market Share by Type (2018-2023)

    Table 29. Global Blood Plasma Derivatives Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 30. Global Blood Plasma Derivatives Revenue Market Share by Type (2024-2029)

    Table 31. Global Blood Plasma Derivatives Market Size by Application (2018-2023) & (US$ Million)

    Table 32. Global Blood Plasma Derivatives Revenue Market Share by Application (2018-2023)

    Table 33. Global Blood Plasma Derivatives Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 34. Global Blood Plasma Derivatives Revenue Market Share by Application (2024-2029)

    Table 35. North America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. North America Blood Plasma Derivatives Market Size by Country (2018-2023) & (US$ Million)

    Table 37. North America Blood Plasma Derivatives Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Europe Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Europe Blood Plasma Derivatives Market Size by Country (2018-2023) & (US$ Million)

    Table 40. Europe Blood Plasma Derivatives Market Size by Country (2024-2029) & (US$ Million)

    Table 41. Asia-Pacific Blood Plasma Derivatives Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2018-2023) & (US$ Million)

    Table 43. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2024-2029) & (US$ Million)

    Table 44. Latin America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Latin America Blood Plasma Derivatives Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Latin America Blood Plasma Derivatives Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Middle East & Africa Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 48. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2024-2029) & (US$ Million)

    Table 50. Grifols Company Detail

    Table 51. Grifols Business Overview

    Table 52. Grifols Blood Plasma Derivatives Product

    Table 53. Grifols Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 54. Grifols Recent Development

    Table 55. SK Plasma Company Detail

    Table 56. SK Plasma Business Overview

    Table 57. SK Plasma Blood Plasma Derivatives Product

    Table 58. SK Plasma Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 59. SK Plasma Recent Development

    Table 60. Fusion Health Care Company Detail

    Table 61. Fusion Health Care Business Overview

    Table 62. Fusion Health Care Blood Plasma Derivatives Product

    Table 63. Fusion Health Care Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 64. Fusion Health Care Recent Development

    Table 65. Biotest AG Company Detail

    Table 66. Biotest AG Business Overview

    Table 67. Biotest AG Blood Plasma Derivatives Product

    Table 68. Biotest AG Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 69. Biotest AG Recent Development

    Table 70. Green Cross Corporation Company Detail

    Table 71. Green Cross Corporation Business Overview

    Table 72. Green Cross Corporation Blood Plasma Derivatives Product

    Table 73. Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 74. Green Cross Corporation Recent Development

    Table 75. Baxter International Company Detail

    Table 76. Baxter International Business Overview

    Table 77. Baxter International Blood Plasma Derivatives Product

    Table 78. Baxter International Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 79. Baxter International Recent Development

    Table 80. LFB Company Detail

    Table 81. LFB Business Overview

    Table 82. LFB Blood Plasma Derivatives Product

    Table 83. LFB Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 84. LFB Recent Development

    Table 85. Octapharma AG Company Detail

    Table 86. Octapharma AG Business Overview

    Table 87. Octapharma AG Blood Plasma Derivatives Product

    Table 88. Octapharma AG Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 89. Octapharma AG Recent Development

    Table 90. CSL Limited Company Detail

    Table 91. CSL Limited Business Overview

    Table 92. CSL Limited Blood Plasma Derivatives Product

    Table 93. CSL Limited Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 94. CSL Limited Recent Development

    Table 95. Takeda Company Detail

    Table 96. Takeda Business Overview

    Table 97. Takeda Blood Plasma Derivatives Product

    Table 98. Takeda Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 99. Takeda Recent Development

    Table 100. China Biologic Products Company Detail

    Table 101. China Biologic Products Business Overview

    Table 102. China Biologic Products Blood Plasma Derivatives Product

    Table 103. China Biologic Products Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 104. China Biologic Products Recent Development

    Table 105. Kedrion Biopharma Company Detail

    Table 106. Kedrion Biopharma Business Overview

    Table 107. Kedrion Biopharma Blood Plasma Derivatives Product

    Table 108. Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 109. Kedrion Biopharma Recent Development

    Table 110. BDI Pharma Company Detail

    Table 111. BDI Pharma Business Overview

    Table 112. BDI Pharma Blood Plasma Derivatives Product

    Table 113. BDI Pharma Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 114. BDI Pharma Recent Development

    Table 115. Bayer AG Company Detail

    Table 116. Bayer AG Business Overview

    Table 117. Bayer AG Blood Plasma Derivatives Product

    Table 118. Bayer AG Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 119. Bayer AG Recent Development

    Table 120. Hualan Biological Engineering Company Detail

    Table 121. Hualan Biological Engineering Business Overview

    Table 122. Hualan Biological Engineering Blood Plasma Derivatives Product

    Table 123. Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2018-2023) & (US$ Million)

    Table 124. Hualan Biological Engineering Recent Development

    Table 125. Research Programs/Design for This Report

    Table 126. Key Data Information from Secondary Sources

    Table 127. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Blood Plasma Derivatives Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Blood Plasma Derivatives Market Share by Type: 2022 VS 2029

    Figure 3. Albumin Features

    Figure 4. Factor VIII Features

    Figure 5. Factor IX Features

    Figure 6. Immunoglobulin Features

    Figure 7. Hyperimmune Globulin Features

    Figure 8. Others Features

    Figure 9. Global Blood Plasma Derivatives Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Blood Plasma Derivatives Market Share by Application: 2022 VS 2029

    Figure 11. Hospitals Case Studies

    Figure 12. Clinics Case Studies

    Figure 13. Other End Users Case Studies

    Figure 14. Blood Plasma Derivatives Report Years Considered

    Figure 15. Global Blood Plasma Derivatives Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Blood Plasma Derivatives Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Blood Plasma Derivatives Market Share by Region: 2022 VS 2029

    Figure 18. Global Blood Plasma Derivatives Market Share by Players in 2022

    Figure 19. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Blood Plasma Derivatives Revenue in 2022

    Figure 21. North America Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Blood Plasma Derivatives Market Share by Country (2018-2029)

    Figure 23. United States Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Blood Plasma Derivatives Market Share by Country (2018-2029)

    Figure 27. Germany Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Blood Plasma Derivatives Market Share by Region (2018-2029)

    Figure 35. China Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Blood Plasma Derivatives Market Share by Country (2018-2029)

    Figure 43. Mexico Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Blood Plasma Derivatives Market Share by Country (2018-2029)

    Figure 47. Turkey Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Blood Plasma Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Grifols Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 50. SK Plasma Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 51. Fusion Health Care Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 52. Biotest AG Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 53. Green Cross Corporation Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 54. Baxter International Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 55. LFB Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 56. Octapharma AG Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 57. CSL Limited Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 58. Takeda Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 59. China Biologic Products Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 60. Kedrion Biopharma Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 61. BDI Pharma Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 62. Bayer AG Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 63. Hualan Biological Engineering Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2023)

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed